Cresset Asset Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,216
Closed -$263K 1795
2025
Q4
$263K Sell
11,216
-5,500
-33% -$119K ﹤0.01% 1360
2025
Q3
$333K Hold
16,716
﹤0.01% 1199
2025
Q2
$229K Sell
16,716
-271
-2% -$2.6K ﹤0.01% 1246
2025
Q1
$188K Buy
16,987
+271
+2% +$2.89K ﹤0.01% 1540
2024
Q4
$178K Hold
16,716
﹤0.01% 1581
2024
Q3
$212K Hold
16,716
﹤0.01% 1959
2024
Q2
$280K Sell
16,716
-133
-0.8% -$1.89K ﹤0.01% 1745
2024
Q1
$253K Buy
16,849
+133
+0.8% +$2.17K ﹤0.01% 1665
2023
Q4
$251K Hold
16,716
﹤0.01% 1584
2023
Q3
$234K Sell
16,716
-477
-3% -$7.66K ﹤0.01% 1549
2023
Q2
$178K Buy
+17,193
New +$190K ﹤0.01% 1757

Other funds holding URGN